leadf
logo-loader
viewNemaura Medical Inc
(
NASDAQ:NMRD
)

Nemaura Medical teams up with Changing Health to battle Type 2 diabetes in UK and Ireland

It will use daily glucose trend data by Nemaura’s non-invasive sugarBEAT monitor, with Changing Health’s digital health coaching solution

Nemaura Medical Inc - Nemaura Medical Inc teaming with Changing Health to improve the management, reversal and prevention of Type 2 diabetes starting in the UK and Ireland
UK-based Changing Health is a provider of digital coaching services to the National Health Service England

Nemaura Medical Inc (NASDAQ:NMRD), the maker of the SugarBEAT continuous glucose monitor, announced Tuesday it is teaming with Changing Health to improve the management, reversal and prevention of Type 2 diabetes starting in the UK and Ireland. 

UK-based Changing Health is a provider of digital coaching services to the National Health Service England, aimed at the prevention or reversal of Type 2 diabetes. 

The partnership will utilize daily glucose trend data provided by Nemaura’s non-invasive sugarBEAT monitor, combined with Changing Health’s evidence-based digital health coaching solution -- which has been the subject of multiple peer-reviewed journal articles demonstrating proven outcomes in the reduction of HbA1c (average blood sugar levels) and weight loss. 

READ: Nemaura unveils Type 2 diabetes management app as companion to its SugarBEAT glucose monitor

The collaboration with Changing Health is one of a number of initiatives Nemaura is embarking upon, as it seeks to improve how people with diabetes and prediabetes can manage, reverse and prevent Type 2 diabetes through its BEAT diabetes health subscription service coupled with sugarBEAT across the digital health, wearable health-tech and diabetes sectors.

“We are delighted to enter into this collaboration with Changing Health, a leading global force in behavioral change programs,” said Nemaura CEO Dr Faz Chowdhury in a statement.

“This collaboration is part of our continued commitment to add further services to our BEAT diabetes program aimed at improving management of diabetes and reversing or preventing Type 2 diabetes.”

Mike Trenell, founder and chairman of Changing Health, said the collaboration “will become a disruptive force” in the medical-technology space.  

“Empowering people with Type 2 diabetes with a real-time view of how they’re managing their condition each day is the best motivator there can be, and we’re looking forward to working with Nemaura to create positive behavioral change at scale,” he said. 

The Loughborough, England company’s SugarBEAT consists of a daily disposable adhesive skin-patch connected to a rechargeable transmitter, with an app displaying glucose readings every five minutes for up to 24 hours. What’s unique about SugarBEAT is its skin-patch technology, which the company said offers for painless glucose management.

Nemaura’s stock recently traded up less than 1% to $4.40 a share in New York. 

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Quick facts: Nemaura Medical Inc

Follow
NASDAQ:NMRD

Price: 6.88 USD

Market Cap: $160.36 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Hochschild Mining reveals 'profitable' PEA on its heavy rare earths project...

Hochschild Mining Head of Investor Relations Charles Gordon joined Proactive New York to discuss the Peru-based gold and silver miner's recent developments within its heavy rare earths project, recently renamed Aclara. Gordon says the group recently revealed a preliminary economic assessment...

12 hours, 45 minutes ago

2 min read